The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis
Clinical trial NCT05133297 · COMPLETED
Trial details
- NCT number
- NCT05133297
- Sponsor
- Hangzhou Highlightll Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-16
- Primary completion
- 2022-12-19
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.